Oct 29
Earnings call
Q2 2027 earnings call
Loras Labs reported Q2 total income from operations of 2,206 crore and a 34.5% EBITDA margin; small molecule CDMO sales grew 86% to 875 crores, affordable medicines revenue grew 15% to 1,302 crores, and peptide capacity was over 16,000 liters.